The G2019S LRRK2 mutation in Brazilian patients with Parkinson's disease:: Phenotype in monozygotic twins

被引:18
|
作者
Munhoz, Renato P. [1 ]
Wakutani, Yosuke [2 ]
Marras, Connie [3 ]
Teive, Helio A. [1 ]
Raskin, Salmo [4 ]
Werneck, Lineu C. [1 ]
Moreno, Danielle [2 ]
Sato, Christine [2 ]
Lang, Anthony E. [3 ,5 ]
Rogaeva, Ekaterina [2 ,5 ]
机构
[1] Univ Fed Parana, Hosp Clin, Neurol Serv, Movement Disorders Unit, Curitiba, Parana, Brazil
[2] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada
[3] Univ Toronto, Toronto Western Hosp, Movement Disorders Ctr, Toronto, ON, Canada
[4] Genet Lab, Curitiba, Parana, Brazil
[5] Univ Hlth Network, Dept Med, Div Neurol, Toronto, ON, Canada
关键词
mutation; Parkinson's disease; G2919S; LRRK; Brazil;
D O I
10.1002/mds.21832
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Mutations in the Leucine-Rich Repeat Kinase 2 gene (LRRK2) are mainly responsible for idiopathic Parkinson's disease (PD) with either a dominant pattern of transmission or a sporadic occurrence due to the reduced penetrance. A majority of LRRK2 kindreds demonstrate an extremely variable age-at-onset in affected members of the same family. The G2019S is the most common LRRK2 mutation, which accounts for 1-5% PD patients in North America, and up to 40% of patients from an isolated Arab population. We assessed the frequency of the G2019S mutation in 83 Brazilian PD patients originally preselected for having an early age-at-onset (< 50 years) and/or a positive family history. The mutation was detected in three probands (3.5%). Our clinical findings in these kindreds include the first description of the phenotype in identical twins discordant for handedness (a general phenomenon found in similar to 25% monozygotic twins). However, both twins developed right asymmetric PD. The clinical presentation of twins was strikingly similar including an identical PD onset at age 60. This observation may suggest that genetic factors predominantly determine age-at-onset. (C) 2007 Movement Disorder Society.
引用
下载
收藏
页码:290 / 294
页数:5
相关论文
共 50 条
  • [41] Worldwide frequency of G2019S LRRK2 mutation in Parkinson's disease: A systematic review
    Guedes, L. Correia
    Ferreira, J. J.
    Rosa, M. M.
    Coelho, M.
    Bonifati, V.
    Sampaio, C.
    PARKINSONISM & RELATED DISORDERS, 2010, 16 (04) : 237 - 242
  • [42] Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's disease
    Kay, Denise M.
    Bird, Tom D.
    Zabetian, Cyrus P.
    Factor, Stewart A.
    Samii, Ali
    Higgins, Donald S.
    Nutt, John
    Roberts, John W.
    Griffith, Alida
    Leis, Berta C.
    Montimurro, Jennifer S.
    Philpott, Sean
    Payami, Haydeh
    GENETIC TESTING, 2006, 10 (03): : 221 - 227
  • [43] Leukocyte MAPK activity associated with the LRRK2 G2019S mutation and Parkinson's disease
    Aasly, J. O.
    Toft, M.
    Farrer, M. J.
    Kvam, S. N.
    White, L. R.
    MOVEMENT DISORDERS, 2006, 21 : S416 - S416
  • [44] LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India
    Vijayan, Bejoy
    Gopala, Srinivas
    Kishore, Asha
    NEUROLOGY INDIA, 2011, 59 (02) : 157 - 160
  • [45] The G2019S LRRK2 mutation is frequent in north African families with Parkinson's disease
    Lesage, S.
    Ibanez, P.
    Lohmann, E.
    Pollak, P.
    Tison, F.
    Tazir, M.
    Leutenegger, A. L.
    Guimaraes, J.
    Bonnet, A. M.
    Durr, A.
    Brice, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2005, 12 : 31 - 32
  • [46] A meta-analysis of the prevalence of the mutation LRRK2 G2019S in patients with Parkinson's disease in Africa
    Wahmane, Sofiane Ait
    Achbani, Abderrahmane
    Elatiqi, Mohamed
    Belmouden, Ahmed
    Nejmeddine, Mohamed
    GENE REPORTS, 2021, 24
  • [47] Parkinson Disease Phenotype in Ashkenazi Jews With and Without LRRK2 G2019S Mutations
    Alcalay, Roy N.
    Mirelman, Anat
    Saunders-Pullman, Rachel
    Tang, Ming-X
    Mejia Santana, Helen
    Raymond, Deborah
    Roos, Ernest
    Orbe-Reilly, Martha
    Gurevich, Tanya
    Bar Shira, Anat
    Weisz, Mali Gana
    Yasinovsky, Kira
    Zalis, Maayan
    Thaler, Avner
    Deik, Andres
    Barrett, Matthew James
    Cabassa, Jose
    Groves, Mark
    Hunt, Ann L.
    Lubarr, Naomi
    San Luciano, Marta
    Miravite, Joan
    Palmese, Christina
    Sachdev, Rivka
    Sarva, Harini
    Severt, Lawrence
    Shanker, Vicki
    Swan, Matthew Carrington
    Soto-Valencia, Jeannie
    Johannes, Brooke
    Ortega, Robert
    Fahn, Stanley
    Cote, Lucien
    Waters, Cheryl
    Mazzoni, Pietro
    Ford, Blair
    Louis, Elan
    Levy, Oren
    Rosado, Llency
    Ruiz, Diana
    Dorovski, Tsvyatko
    Pauciulo, Michael
    Nichols, William
    Orr-Urtreger, Avi
    Ozelius, Laurie
    Clark, Lorraine
    Giladi, Nir
    Bressman, Susan
    Marder, Karen S.
    MOVEMENT DISORDERS, 2013, 28 (14) : 1966 - 1971
  • [48] The LRRK2 G2019S mutation in a series of Argentinean patients with Parkinson's disease: Clinical and demographic characteristics
    Mabel Gatto, Emilia
    Parisi, Virginia
    Paola Converso, Daniela
    Jose Poderoso, Juan
    Cecilia Carreras, Maria
    Felix Marti-Masso, Jose
    Paisan-Ruiz, Coro
    NEUROSCIENCE LETTERS, 2013, 537 : 1 - 5
  • [49] LRRK2 G2019S mutation: frequency and haplotype data in South African Parkinson's disease patients
    Bardien, Soraya
    Marsberg, Angelica
    Keyser, Rowena
    Lombard, Debbie
    Lesage, Suzanne
    Brice, Alexis
    Carr, Jonathan
    JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (07) : 847 - 853
  • [50] The LRRK2 G2019S mutation in Ashkenazi Jews with Parkinson disease -: Is there a gender effect?
    Orr-Urtreger, A.
    Shifrin, C.
    Rozovski, U.
    Rosner, S.
    Bercovich, D.
    Gurevich, T.
    Yagev-More, H.
    Bar-Shira, A.
    Giladi, N.
    NEUROLOGY, 2007, 69 (16) : 1595 - 1602